Blockade of motion- and cisplatin-induced emesis by a 5-HT2 receptor agonist in Suncus murinus
- PMID: 7780647
- PMCID: PMC1510319
- DOI: 10.1111/j.1476-5381.1995.tb13293.x
Blockade of motion- and cisplatin-induced emesis by a 5-HT2 receptor agonist in Suncus murinus
Abstract
1. The effects of (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOl), a 5-hydroxytryptamine 5-HT2A/5-HT2C receptor agonist, on motion- and cisplatin-induced emesis were studied in Suncus murinus. Subcutaneous injection of DOl, 30 min prior to the emetic stimuli, dose-dependently blocked the emesis induced by motion sickness and cisplatin (20 mg kg-1, i.p.) with estimated ID50 values of 640 and 780 micrograms kg-1, respectively. 2. alpha-Methyl-5-hydroxytryptamine (alpha-Me-5-HT), a peripheral 5-HT2A/5-HT2C receptor agonist, had no effect on motion- and cisplatin-induced emesis. 3. The antiemetic effects of DOl on motion- and cisplatin-induced emesis were attenuated by preadministration of ketanserin, a selective 5-HT2A receptor antagonist. 4. The present results suggest an inhibitory role for central 5-HT2 receptors in the emetic reflex mechanism and that a 5-HT2 receptor agonist may be a useful tool to investigate the involvement of 5-HT receptors in the emetic reflex.
Similar articles
-
Further investigation of the effects of 5-hydroxytryptamine, 8-OH-DPAT and DOI to mediate contraction and relaxation responses in the intestine and emesis in Suncus murinus.Eur J Pharmacol. 2018 Feb 15;821:79-87. doi: 10.1016/j.ejphar.2017.12.051. Epub 2017 Dec 23. Eur J Pharmacol. 2018. PMID: 29277716
-
Antiemetic effects of serotonergic 5-HT1A-receptor agonists in Suncus murinus.Jpn J Pharmacol. 1994 Feb;64(2):109-14. doi: 10.1254/jjp.64.109. Jpn J Pharmacol. 1994. PMID: 8028227
-
The effect of serotonin and serotonin receptor antagonists on motion sickness in Suncus murinus.Pharmacol Biochem Behav. 2002 Nov;73(4):979-89. doi: 10.1016/s0091-3057(02)00955-3. Pharmacol Biochem Behav. 2002. PMID: 12213545
-
The involvement of TRPV1 in emesis and anti-emesis.Temperature (Austin). 2015 May 21;2(2):258-76. doi: 10.1080/23328940.2015.1043042. eCollection 2015 Apr-Jun. Temperature (Austin). 2015. PMID: 27227028 Free PMC article. Review.
-
Neuropharmacology of motion sickness and emesis. A review.Acta Otolaryngol Suppl. 1993;501:10-5. doi: 10.3109/00016489309126205. Acta Otolaryngol Suppl. 1993. PMID: 8447218 Review.
Cited by
-
DSP-1053, a novel serotonin reuptake inhibitor with 5-HT1A partial agonistic activity, displays fast antidepressant effect with minimal undesirable effects in juvenile rats.Pharmacol Res Perspect. 2015 Jun;3(3):e00142. doi: 10.1002/prp2.142. Epub 2015 May 8. Pharmacol Res Perspect. 2015. PMID: 26171224 Free PMC article.
-
Evaluating proxies for motion sickness in rodent.IBRO Neurosci Rep. 2023 Jul 8;15:107-115. doi: 10.1016/j.ibneur.2023.06.006. eCollection 2023 Dec. IBRO Neurosci Rep. 2023. PMID: 38204574 Free PMC article.
-
Olanzapine Administration Reduces Chemotherapy-Induced Nausea Behavior in Rats.Biol Res Nurs. 2021 Oct;23(4):584-595. doi: 10.1177/10998004211000443. Epub 2021 Apr 1. Biol Res Nurs. 2021. PMID: 33789505 Free PMC article.
-
A pilot study of rizatriptan and visually-induced motion sickness in migraineurs.Int J Med Sci. 2009 Aug 6;6(4):212-7. doi: 10.7150/ijms.6.212. Int J Med Sci. 2009. PMID: 19680473 Free PMC article. Clinical Trial.
-
Synthetic and natural antioxidants attenuate cisplatin-induced vomiting.BMC Pharmacol Toxicol. 2017 Jan 13;18(1):4. doi: 10.1186/s40360-016-0110-9. BMC Pharmacol Toxicol. 2017. PMID: 28081725 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical